Skip to content

Clinical trials

Phase 2 Immunoglobulin G4-Related Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin G4-Related Disease Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20181
20201
20211
20221
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Not yet recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital2
Amgen1
Chinese PLA General Hospital1
Massachusetts General Hospital1
Matthew C. Baker1
National Institute of Allergy and Infectious Diseases (NIAID)1
Peking University People's Hospital1
Principia Biopharma, a Sanofi Company1
Stanford University1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin G4-Related Disease12
Behcet Syndrome2
Myositis2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Antiphospholipid Syndrome1
Autoimmune Diseases1
Lupus Erythematosus, Systemic1
Purpura, Thrombotic Thrombocytopenic1
Recurrence1
Scleroderma, Systemic1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.